Pharmaceutical
Manufacturing
Health

Akorn

$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (4.17%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Akorn and other stocks, options, ETFs, and crypto commission-free!

About

Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. Read More The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Employees
2,220
Headquarters
Lake Forest, Illinois
Founded
1971
Market Cap
421.65M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
3.06M
High Today
$3.53
Low Today
$3.35
Open Price
$3.35
Volume
1.07M
52 Week High
$19.81
52 Week Low
$3.14

Collections

Pharmaceutical
Manufacturing
Health
Health And Wellness

News

PR NewswireMar 21

AKORN INVESTOR NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important April 22nd Deadline in Securities Class Action Lawsuit Filed by the Firm

NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc.

132
StreetInsiderMar 21

Form 8-K AKORN INC For: Mar 21

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 __________________________________ Date of Report (Date of earliest event reported): March 21, 2019 Akorn, Inc. (Exact name of registrant as specified in charter) Louisiana 001-32360 72-0717400 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)...

34
Yahoo FinanceMar 20

Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update

NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

257

Earnings

-$0.70
-$0.33
$0.03
$0.40
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.